LATESTSEARCH ⌕
NASDAQ / LIVE COMPANY INTELLIGENCE

Aptevo Therapeutics Inc.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERAPVO
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / APVO COVERAGE

What’s moving Aptevo Therapeutics Inc. now

Current reporting with the operating signal separated from the noise.

01
APVO: Initiating Coverage of Aptevo Therapeutics Inc.; Unlocking the Next Generation of Multispecific Immune Engagement

APVO: Initiating Coverage of Aptevo Therapeutics Inc.; Unlocking the Next Generation of Multispecific Immune Engagement

The story matters when it changes Aptevo Therapeutics Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
02
Aptevo Therapeutics Inc. Announces Pricing of $5 Million Public Offering

Aptevo Therapeutics Inc. Announces Pricing of $5 Million Public Offering

The story matters when it changes Aptevo Therapeutics Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
03
Aptevo Therapeutics Inc. (APVO): Are Hedge Funds Right About This Stock?

Aptevo Therapeutics Inc. (APVO): Are Hedge Funds Right About This Stock?

Investors are testing whether Aptevo Therapeutics Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
04
How Aptevo Therapeutics Inc (APVO) Stacks Up Against Its Peers

How Aptevo Therapeutics Inc (APVO) Stacks Up Against Its Peers

The development tests whether Aptevo Therapeutics Inc. can turn product investment into adoption, revenue and durable advantage.

Watch next: confirmation in a company filing, official release or regulator record.
PRIMARY DOCUMENTS / SEC EDGAR

Latest APVO filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-05-13 · Period 2026-03-31SEC ↗10-QQuarterly financial reportFiled 2025-11-06 · Period 2025-09-30SEC ↗10-KAnnual financial reportFiled 2026-03-26 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-07-27 · Period 2026-07-27SEC ↗8-KMaterial company eventFiled 2026-06-30 · Period 2026-06-29SEC ↗8-KMaterial company eventFiled 2026-05-27 · Period 2026-05-25SEC ↗DEF 14AProxy and shareholder meetingFiled 2026-07-31 · Period 2026-07-31SEC ↗ARSOfficial SEC filingFiled 2026-07-31 · Period 2025-12-31SEC ↗
EARNINGS / QUARTERLY TRACKER

Aptevo Therapeutics Inc., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.